[RISK FACTORS FOR INTRAVESICAL RECURRENCE AFTER SURGICAL MANAGEMENT OF UROTHERIAL CARCINOMA OF THE UPPER URINARY TRACT].

OBJECTIVES To identify risk factors for developing recurrent bladder cancer in patients who underwent surgical resection for urothelial carcinoma of the upper urinary tract. METHODS We retrospectively analyzed 322 patients who underwent surgical resection for urothelial carcinoma of the upper urinary tract at the Jikei University Hospital and our affiliated hospitals between January 2005 and July 2011. Univariate and multivariate analyses by using the Cox proportional hazards model were performed to determine the risk factors for intravesical recurrence after nephroureterectomy in these 322 patients. RESULTS Of the 322 patients, 111 patients (34.5%) developed recurrent bladder cancer after a median interval of 8.0 months. On multivariate analysis, the presence of a superficial tumor and the presence of a ureteral tumor were independent predictors for intravesical recurrence. CONCLUSION The risk factors for developing recurrent bladder cancer were the presence of a superficial tumor and the presence of a ureteral tumor. Further investigation is required to evaluate the efficacy of perioperative intravesical therapy for the prevention of intravesical recurrence.

[1]  F. Montorsi,et al.  Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. , 2014, European urology.

[2]  K. Hong,et al.  Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma. , 2014, Urologic oncology.

[3]  Takuhiro Yamaguchi,et al.  Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial. , 2013, Japanese journal of clinical oncology.

[4]  Choung-Soo Kim,et al.  Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. , 2013, Urologic oncology.

[5]  F. Zhou,et al.  Clipping the extremity of ureter prior to nephroureterectomy is effective in preventing subsequent bladder recurrence after upper urinary tract urothelial carcinoma. , 2012, Chinese medical journal.

[6]  T. O'brien,et al.  Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). , 2011, European urology.

[7]  C. Kwak,et al.  Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. , 2011, Urologic oncology.

[8]  C. Tulić,et al.  Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival , 2011, International Urology and Nephrology.

[9]  H. Miyake,et al.  Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. , 2008, Urology.

[10]  K. Yoshimura,et al.  Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. , 2005, Urology.

[11]  F. Koga,et al.  Risk Factors for the Development of Bladder Transitional Cell Carcinoma following Surgery for Transitional Cell Carcinoma of the Upper Urinary Tract , 2001, Urologia Internationalis.

[12]  Y. Jo,et al.  Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract , 2001, International journal of urology : official journal of the Japanese Urological Association.

[13]  N. Masumori,et al.  Risk factors for the development of bladder cancer after upper tract urothelial cancer. , 2000, Urology.